| Year |
Citation |
Score |
| 2020 |
Wang J, Zope H, Islam MA, Rice J, Dodman S, Lipert K, Chen Y, Zetter BR, Shi J. Lipidation Approaches Potentiate Adjuvant-Pulsed Immune Surveillance: A Design Rationale for Cancer Nanovaccine. Frontiers in Bioengineering and Biotechnology. 8: 787. PMID 32850698 DOI: 10.3389/Fbioe.2020.00787 |
0.343 |
|
| 2020 |
Fu L, Zou F, Liu Q, Wang B, Wang J, Liang H, Liang X, Liu J, Shi J, Liu Q. An ultra-long circulating nanoparticle for reviving a highly selective BCR-ABL inhibitor in long-term effective and safe treatment of chronic myeloid leukemia. Nanomedicine : Nanotechnology, Biology, and Medicine. 102283. PMID 32777451 DOI: 10.1016/J.Nano.2020.102283 |
0.35 |
|
| 2020 |
Tao W, Yurdagul A, Kong N, Li W, Wang X, Doran AC, Feng C, Wang J, Islam MA, Farokhzad OC, Tabas I, Shi J. siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice. Science Translational Medicine. 12. PMID 32718990 DOI: 10.1126/Scitranslmed.Aay1063 |
0.314 |
|
| 2020 |
Li Y, Ding J, Xu X, Shi R, Saw PE, Wang J, Chung S, Li W, Aljaeid BM, Lee RJ, Tao W, Teng L, Farokhzad OC, Shi J. Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy. Nano Letters. PMID 32479088 DOI: 10.1021/Acs.Nanolett.0C00757 |
0.355 |
|
| 2020 |
Xiong Q, Li Y, Zhou K, Chen P, Guo H, Chen L, Ding J, Song T, Shi J. Optimized fluorodendrimer-incorporated hybrid lipid-polymer nanoparticles for efficient siRNA delivery. Biomaterials Science. PMID 31965126 DOI: 10.1039/C9Bm01738K |
0.335 |
|
| 2020 |
Lin YX, Wang Y, Blake S, Yu M, Mei L, Wang H, Shi J. RNA Nanotechnology-Mediated Cancer Immunotherapy. Theranostics. 10: 281-299. PMID 31903120 DOI: 10.7150/Thno.35568 |
0.313 |
|
| 2019 |
Kong N, Tao W, Ling X, Wang J, Xiao Y, Shi S, Ji X, Shajii A, Gan ST, Kim NY, Duda DG, Xie T, Farokhzad OC, Shi J. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes -deficient cancers to mTOR inhibition. Science Translational Medicine. 11. PMID 31852795 DOI: 10.1126/Scitranslmed.Aaw1565 |
0.348 |
|
| 2019 |
Lin Y, Wang Y, An HW, Qi B, Wang J, Wang L, Shi J, Mei L, Wang H. Peptide-based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improve Chemotherapy Resistance. Nano Letters. PMID 30924343 DOI: 10.1021/Acs.Nanolett.9B00083 |
0.312 |
|
| 2019 |
Shi B, Zheng M, Jiang T, Yang W, Zou Y, Wu H, Liu X, McDonald K, Ling D, Shi J, Zhu F, Qian R. The siRNAsome: A Cation Free and Versatile Nanostructure for siRNA and Drug Codelivery. Angewandte Chemie (International Ed. in English). PMID 30737876 DOI: 10.1002/Anie.201814289 |
0.327 |
|
| 2018 |
Islam MA, Xu Y, Tao W, Ubellacker JM, Lim M, Aum D, Lee GY, Zhou K, Zope H, Yu M, Cao W, Oswald JT, Dinarvand M, Mahmoudi M, Langer R, ... ... Shi J, et al. Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nature Biomedical Engineering. 2: 850-864. PMID 31015614 DOI: 10.1038/S41551-018-0284-0 |
0.311 |
|
| 2018 |
Xiong Q, Lee GY, Ding J, Li W, Shi J. Biomedical applications of mRNA nanomedicine. Nano Research. 11: 5281-5309. PMID 31007865 DOI: 10.1007/S12274-018-2146-1 |
0.309 |
|
| 2018 |
Yu M, Ortega CA, Si K, Molinaro R, Schoen FJ, Leitao RFC, Xu X, Mahmoudi M, Ahn S, Liu J, Saw PE, Lee IH, Brayner MMB, Lotfi A, Shi J, et al. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Theranostics. 8: 6008-6024. PMID 30613278 DOI: 10.7150/Thno.24365 |
0.315 |
|
| 2018 |
Xu X, Wu J, Liu S, Saw PE, Tao W, Li Y, Krygsman L, Yegnasubramanian S, De Marzo AM, Shi J, Bieberich CJ, Farokhzad OC. Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy. Small (Weinheim An Der Bergstrasse, Germany). e1802565. PMID 30230235 DOI: 10.1002/Smll.201802565 |
0.393 |
|
| 2018 |
Ji X, Kong N, Wang J, Li W, Xiao Y, Gan ST, Zhang Y, Li Y, Song X, Xiong Q, Shi S, Li Z, Tao W, Zhang H, Mei L, ... Shi J, et al. A Novel Top-Down Synthesis of Ultrathin 2D Boron Nanosheets for Multimodal Imaging-Guided Cancer Therapy. Advanced Materials (Deerfield Beach, Fla.). e1803031. PMID 30019786 DOI: 10.1002/Adma.201803031 |
0.321 |
|
| 2018 |
Lin X, Chen X, Riddell IA, Tao W, Wang J, Hollett G, Lippard SJ, Farokhzad OC, Shi J, Wu J. Glutathione-scavenging Poly(disulfide amide) Nanoparticles for Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance. Nano Letters. PMID 29902013 DOI: 10.1021/Acs.Nanolett.8B01924 |
0.355 |
|
| 2017 |
Liu Y, Ji X, Liu J, Tong WWL, Askhatova D, Shi J. Tantalum Sulfide Nanosheets as a Theranostic Nanoplatform for Computed Tomography Imaging-Guided Combinatorial Chemo-Photothermal Therapy. Advanced Functional Materials. 27. PMID 29290753 DOI: 10.1002/Adfm.201703261 |
0.327 |
|
| 2017 |
Liu Y, Ji X, Tong W, Askhatova D, Yang T, Cheng H, Wang Y, Shi J. Engineering Multifunctional RNAi Nanomedicine to Concurrently Target Cancer Hallmarks for Combinatorial Therapy. Angewandte Chemie (International Ed. in English). PMID 29276823 DOI: 10.1002/Anie.201710144 |
0.376 |
|
| 2017 |
Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, et al. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr(-/-) Mice. Advanced Healthcare Materials. PMID 28730752 DOI: 10.1002/Adhm.201700313 |
0.332 |
|
| 2017 |
Xu X, Saw PE, Tao W, Li Y, Ji X, Bhasin S, Liu Y, Ayyash D, Rasmussen J, Huo M, Shi J, Farokhzad OC. ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy. Advanced Materials (Deerfield Beach, Fla.). PMID 28681981 DOI: 10.1002/Adma.201700141 |
0.386 |
|
| 2017 |
Tao W, Ji X, Xu X, Ariful Islam M, Li Z, Chen S, Saw PE, Zhang H, Bharwani Z, Guo Z, Shi J, Farokhzad O. Antimonene Quantum Dots: Synthesis and Application as Near-Infrared Photothermal Agents for Effective Cancer Therapy. Angewandte Chemie (International Ed. in English). PMID 28640986 DOI: 10.1002/Anie.201703657 |
0.346 |
|
| 2017 |
Zhu X, Tao W, Liu D, Wu J, Guo Z, Ji X, Bharwani Z, Zhao L, Zhao X, Farokhzad OC, Shi J. Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo. Theranostics. 7: 1990-2002. PMID 28638484 DOI: 10.7150/Thno.18136 |
0.369 |
|
| 2017 |
Xu X, Saw PE, Tao W, Li Y, Ji X, Yu M, Mahmoudi M, Rasmussen J, Ayyash D, Zhou Y, Farokhzad OC, Shi J. Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy. Nano Letters. PMID 28636389 DOI: 10.1021/Acs.Nanolett.7B01571 |
0.383 |
|
| 2017 |
Xu X, Wu J, Liu Y, Saw PE, Tao W, Yu M, Zope HR, Si M, Victorious A, Rasmussen J, Ayyash D, Farokhzad OC, Shi J. A Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy. Acs Nano. PMID 28240870 DOI: 10.1021/Acsnano.6B07195 |
0.385 |
|
| 2017 |
Islam MA, Xu Y, Zope H, Cao W, Mahmoudi M, Langer R, Kantoff PW, Shi J, Zetter BR, Farokhzad OC. Restoration of tumor suppression in vivo by systemic delivery of chemically-modified PTEN mRNA nanoparticles. Journal of Clinical Oncology. 35: 11582-11582. DOI: 10.1200/Jco.2017.35.15_Suppl.11582 |
0.357 |
|
| 2017 |
Shi J. Abstract B57: RNAi Nanotechnology for Cancer Target Validation and Therapy Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B57 |
0.364 |
|
| 2017 |
Xu Y, Islam MA, Zope H, Mahmoudi M, Langer RS, Shi J, Zetter BR, Farokhzad OC. Abstract 1231: Restoration of tumor suppressionin vivoby systemic delivery of PTEN mRNA nanoparticles Cancer Research. 77: 1231-1231. DOI: 10.1158/1538-7445.Am2017-1231 |
0.357 |
|
| 2016 |
Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nature Reviews. Cancer. PMID 27834398 DOI: 10.1038/Nrc.2016.108 |
0.3 |
|
| 2016 |
Tao W, Zhu X, Yu X, Zeng X, Xiao Q, Zhang X, Ji X, Wang X, Shi J, Zhang H, Mei L. Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer Theranostics. Advanced Materials (Deerfield Beach, Fla.). PMID 27797119 DOI: 10.1002/Adma.201603276 |
0.327 |
|
| 2016 |
Liu Y, Gunda V, Zhu X, Xu X, Wu J, Askhatova D, Farokhzad OC, Parangi S, Shi J. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 27342857 DOI: 10.1073/Pnas.1605841113 |
0.361 |
|
| 2016 |
Xu X, Wu J, Liu Y, Yu M, Zhao L, Zhu X, Bhasin S, Li Q, Ha E, Shi J, Farokhzad OC. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy. Angewandte Chemie (International Ed. in English). PMID 27140428 DOI: 10.1002/Anie.201601273 |
0.375 |
|
| 2016 |
Zhu X, Wu J, Shan W, Tao W, Zhao L, Lim JM, D'Ortenzio M, Karnik R, Huang Y, Shi J, Farokhzad OC. Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins. Angewandte Chemie (International Ed. in English). PMID 26846161 DOI: 10.1002/Anie.201509183 |
0.347 |
|
| 2015 |
Yu M, Wu J, Shi J, Farokhzad OC. Nanotechnology for protein delivery: Overview and perspectives. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26458789 DOI: 10.1016/J.Jconrel.2015.10.012 |
0.318 |
|
| 2015 |
Wu J, Zhao L, Xu X, Bertrand N, Choi WI, Yameen B, Shi J, Shah V, Mulvale M, MacLean JL, Farokhzad OC. Hydrophobic Cysteine Poly(disulfide)-based Redox-Hypersensitive Nanoparticle Platform for Cancer Theranostics. Angewandte Chemie (International Ed. in English). PMID 26119453 DOI: 10.1002/Anie.201503863 |
0.383 |
|
| 2015 |
Mitragotri S, Anderson DG, Chen X, Chow EK, Ho D, Kabanov AV, Karp JM, Kataoka K, Mirkin CA, Petrosko SH, Shi J, Stevens MM, Sun S, Teoh S, Venkatraman SS, et al. Accelerating the Translation of Nanomaterials in Biomedicine. Acs Nano. PMID 26115196 DOI: 10.1021/Acsnano.5B03569 |
0.338 |
|
| 2015 |
Zhu X, Xu Y, Solis LM, Tao W, Wang L, Behrens C, Xu X, Zhao L, Liu D, Wu J, Zhang N, Wistuba II, Farokhzad OC, Zetter BR, Shi J. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proceedings of the National Academy of Sciences of the United States of America. 112: 7779-84. PMID 26056316 DOI: 10.1073/Pnas.1505629112 |
0.406 |
|
| 2014 |
Choi WI, Kamaly N, Riol-Blanco L, Lee IH, Wu J, Swami A, Vilos C, Yameen B, Yu M, Shi J, Tabas I, von Andrian UH, Jon S, Farokhzad OC. A solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins. Nano Letters. 14: 6449-55. PMID 25333768 DOI: 10.1021/Nl502994Y |
0.336 |
|
| 2014 |
Wu J, Kamaly N, Shi J, Zhao L, Xiao Z, Hollett G, John R, Ray S, Xu X, Zhang X, Kantoff PW, Farokhzad OC. Development of multinuclear polymeric nanoparticles as robust protein nanocarriers. Angewandte Chemie (International Ed. in English). 53: 8975-9. PMID 24990548 DOI: 10.1002/Anie.201404766 |
0.329 |
|
| 2014 |
Yameen B, Choi WI, Vilos C, Swami A, Shi J, Farokhzad OC. Insight into nanoparticle cellular uptake and intracellular targeting. Journal of Controlled Release : Official Journal of the Controlled Release Society. 190: 485-99. PMID 24984011 DOI: 10.1016/J.Jconrel.2014.06.038 |
0.348 |
|
| 2014 |
Swami A, Reagan MR, Basto P, Mishima Y, Kamaly N, Glavey S, Zhang S, Moschetta M, Seevaratnam D, Zhang Y, Liu J, Memarzadeh M, Wu J, Manier S, Shi J, et al. Engineered nanomedicine for myeloma and bone microenvironment targeting. Proceedings of the National Academy of Sciences of the United States of America. 111: 10287-92. PMID 24982170 DOI: 10.1073/Pnas.1401337111 |
0.337 |
|
| 2014 |
Gadde S, Even-Or O, Kamaly N, Hasija A, Gagnon PG, Adusumilli KH, Erakovic A, Pal AK, Zhang XQ, Kolishetti N, Shi J, Fisher EA, Farokhzad OC. Development of therapeutic polymeric nanoparticles for the resolution of inflammation. Advanced Healthcare Materials. 3: 1448-56. PMID 24659608 DOI: 10.1002/Adhm.201300688 |
0.323 |
|
| 2014 |
Shi J, Xu Y, Xu X, Zhu X, Pridgen E, Wu J, Votruba AR, Swami A, Zetter BR, Farokhzad OC. Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 897-900. PMID 24650883 DOI: 10.1016/J.Nano.2014.03.006 |
0.361 |
|
| 2014 |
Ilyinskii PO, Roy CJ, O'Neil CP, Browning EA, Pittet LA, Altreuter DH, Alexis F, Tonti E, Shi J, Basto PA, Iannacone M, Radovic-Moreno AF, Langer RS, Farokhzad OC, von Andrian UH, et al. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine. 32: 2882-95. PMID 24593999 DOI: 10.1016/J.Vaccine.2014.02.027 |
0.303 |
|
| 2013 |
Xu X, Xie K, Zhang XQ, Pridgen EM, Park GY, Cui DS, Shi J, Wu J, Kantoff PW, Lippard SJ, Langer R, Walker GC, Farokhzad OC. Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug. Proceedings of the National Academy of Sciences of the United States of America. 110: 18638-43. PMID 24167294 DOI: 10.1073/Pnas.1303958110 |
0.349 |
|
| 2013 |
Shi J, Xu Y, Xu X, Votruba A, Zhu X, Pridgen E, Xiao Z, Langer R, Zetter BR, Farokhzad OC. Abstract 4529: Self-assembled lipid-polymer hybrid nanoparticles for the sustained delivery of siRNA and the treatment of drug-resistant cancers. Cancer Research. 73: 4529-4529. DOI: 10.1158/1538-7445.Am2013-4529 |
0.395 |
|
| 2012 |
Xiao Z, Ji C, Shi J, Pridgen EM, Frieder J, Wu J, Farokhzad OC. DNA self-assembly of targeted near-infrared-responsive gold nanoparticles for cancer thermo-chemotherapy. Angewandte Chemie (International Ed. in English). 51: 11853-7. PMID 23081716 DOI: 10.1002/Anie.201204018 |
0.312 |
|
| 2012 |
Xiao Z, Levy-Nissenbaum E, Alexis F, Lupták A, Teply BA, Chan JM, Shi J, Digga E, Cheng J, Langer R, Farokhzad OC. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. Acs Nano. 6: 696-704. PMID 22214176 DOI: 10.1021/Nn204165V |
0.369 |
|
| 2012 |
Shi J, Votruba AR, Xu X, Langer R, Zetter BR, Farokhzad OC. Abstract 2896: Nanoparticle co-delivery of RNAi and chemotherapy for the treatment of drug-resistant cancers Cancer Research. 72: 2896-2896. DOI: 10.1158/1538-7445.Am2012-2896 |
0.378 |
|
| 2011 |
Shi J, Xiao Z, Votruba AR, Vilos C, Farokhzad OC. Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. Angewandte Chemie (International Ed. in English). 50: 7027-31. PMID 21698724 DOI: 10.1002/Anie.201101554 |
0.342 |
|
| 2011 |
Shi J, Xiao Z, Kamaly N, Farokhzad OC. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Accounts of Chemical Research. 44: 1123-34. PMID 21692448 DOI: 10.1021/Ar200054N |
0.353 |
|
| 2010 |
Gao W, Xiao Z, Radovic-Moreno A, Shi J, Langer R, Farokhzad OC. Progress in siRNA delivery using multifunctional nanoparticles. Methods in Molecular Biology (Clifton, N.J.). 629: 53-67. PMID 20387142 DOI: 10.1007/978-1-60761-657-3_4 |
0.344 |
|
| 2008 |
Shi J, Yang T, Cremer PS. Multiplexing ligand-receptor binding measurements by chemically patterning microfluidic channels. Analytical Chemistry. 80: 6078-84. PMID 18570383 DOI: 10.1021/Ac800912F |
0.494 |
|
| 2008 |
Shi J, Chen J, Cremer PS. Sub-100 nm patterning of supported bilayers by nanoshaving lithography. Journal of the American Chemical Society. 130: 2718-9. PMID 18257567 DOI: 10.1021/Ja077730S |
0.625 |
|
| 2008 |
Jung H, Yang T, Lasagna MD, Shi J, Reinhart GD, Cremer PS. Impact of hapten presentation on antibody binding at lipid membrane interfaces. Biophysical Journal. 94: 3094-103. PMID 18199665 DOI: 10.1529/Biophysj.107.115519 |
0.603 |
|
| 2007 |
Shi J, Yang T, Kataoka S, Zhang Y, Diaz AJ, Cremer PS. GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes. Journal of the American Chemical Society. 129: 5954-61. PMID 17429973 DOI: 10.1021/Ja069375W |
0.496 |
|
| Show low-probability matches. |